Frazier-Life-Sciences-Management-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "ASND",
  "TRVI",
  "ALKS",
  "KRYS",
  "NAMS",
  "ARQT",
  "RVMD",
  "ORIC",
  "ACAD",
  "MREO",
  "RCKT",
  "ALLO",
  "SLN",
  "IMTX",
  "SVRA",
  "MIRM",
  "PHAT",
  "ADVM",
  "AUTL",
  "TARS",
  "KALV",
  "MGNX",
  "LXEO",
  null,
  "PVLA",
  null,
  "RNA",
  "AGIO",
  "MBX",
  "RYTM",
  "SLNO",
  "COGT",
  "DYN",
  "ELEV",
  "ERAS",
  "IMCR",
  "DSGN",
  "HLVX",
  "VRNA",
  "ZLAB",
  "ORKA",
  "RARE",
  "PCVX",
  "BBIO",
  "CGON",
  "IRON"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 47
Total Value: 2187908599
Accession Number: 0001892134-25-000005
Form Type: 13F-HR
CIK: frazier-life-sciences-management-lp
Manager Name: Frazier-Life-Sciences-Management-Lp

Data Enrichment

96% identified

45 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

47 positions • $2.2B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 3

Sort by:

Ascendis Pharma A/S

ASND|04351P101

Shares:133.3K

Value:$20.8M

% of Portfolio:0.9% ($20.8M/$2.2B)

Vaxcyte, Inc.

PCVX|92243G108

Shares:539.4K

Value:$20.4M

% of Portfolio:0.9% ($20.4M/$2.2B)

Alkermes plc.

ALKS|G01767105

Shares:601.1K

Value:$19.8M

% of Portfolio:0.9% ($19.8M/$2.2B)

PALVELLA THERAPEUTICS, INC.

PVLA|697947109

Shares:690.0K

Value:$19.3M

% of Portfolio:0.9% ($19.3M/$2.2B)

CG Oncology, Inc.

CGON|156944100

Shares:770.0K

Value:$18.9M

% of Portfolio:0.9% ($18.9M/$2.2B)

Mereo BioPharma Group plc

MREO|589492107

Shares:7.8M

Value:$17.6M

% of Portfolio:0.8% ($17.6M/$2.2B)

Merus N.V.

MRUS|N5749R100

Shares:373.1K

Value:$15.7M

% of Portfolio:0.7% ($15.7M/$2.2B)

Avidity Biosciences, Inc.

RNA|05370A108

Shares:525.0K

Value:$15.5M

% of Portfolio:0.7% ($15.5M/$2.2B)

HilleVax, Inc.

HLVX|43157M102

Shares:10.6M

Value:$15.4M

% of Portfolio:0.7% ($15.4M/$2.2B)

Dyne Therapeutics, Inc.

DYN|26818M108

Shares:1.4M

Value:$15.1M

% of Portfolio:0.7% ($15.1M/$2.2B)

Zai Lab Ltd

ZLAB|98887Q104

Shares:350.0K

Value:$12.6M

% of Portfolio:0.6% ($12.6M/$2.2B)

Immunocore Holdings plc

IMCR|45258D105

Shares:301.2K

Value:$8.9M

% of Portfolio:0.4% ($8.9M/$2.2B)

Oric Pharmaceuticals, Inc.

ORIC|68622P109

Shares:1.4M

Value:$7.9M

% of Portfolio:0.4% ($7.9M/$2.2B)

ACADIA PHARMACEUTICALS INC

ACAD|004225108

Shares:470.3K

Value:$7.8M

% of Portfolio:0.4% ($7.8M/$2.2B)

Design Therapeutics, Inc.

DSGN|25056L103

Shares:2.0M

Value:$7.5M

% of Portfolio:0.3% ($7.5M/$2.2B)

ROCKET PHARMACEUTICALS, INC.

RCKT|77313F106

Shares:1.1M

Value:$7.2M

% of Portfolio:0.3% ($7.2M/$2.2B)

Autolus Therapeutics plc

AUTL|05280R100

Shares:4.6M

Value:$7.2M

% of Portfolio:0.3% ($7.2M/$2.2B)

Oruka Therapeutics, Inc.

ORKA|687604108

Shares:583.3K

Value:$6.0M

% of Portfolio:0.3% ($6.0M/$2.2B)

Allogene Therapeutics, Inc.

ALLO|019770106

Shares:3.9M

Value:$5.6M

% of Portfolio:0.3% ($5.6M/$2.2B)

Immatics N.V.

IMTX|N44445109

Shares:1.2M

Value:$5.6M

% of Portfolio:0.3% ($5.6M/$2.2B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Ascendis Pharma A/S(ASNDcusip04351P101)	133.3K	QoQ 0.00% (+0) YoY NEW(+133.3K)	All Managers (Combined)	$20.8M	0.9% ($20.8M/$2.2B)	QoQ +13.21% (+$2.4M) YoY NEW(+$20.8M)
Vaxcyte, Inc.(PCVXcusip92243G108)	539.4K	QoQ 0.00% (-0) YoY -52.65% (-600.0K)	All Managers (Combined)	$20.4M	0.9% ($20.4M/$2.2B)	QoQ -53.87% (-$23.8M) YoY -73.83% (-$57.5M)
Alkermes plc.(ALKScusipG01767105)	601.1K	QoQ 0.00% (+0) YoY NEW(+601.1K)	All Managers (Combined)	$19.8M	0.9% ($19.8M/$2.2B)	QoQ +14.81% (+$2.6M) YoY NEW(+$19.8M)
PALVELLA THERAPEUTICS, INC.(PVLAcusip697947109)	690.0K	QoQ +5.52% (+36.1K) YoY NEW(+690.0K)	All Managers (Combined)	$19.3M	0.9% ($19.3M/$2.2B)	QoQ +146.13% (+$11.5M) YoY NEW(+$19.3M)
CG Oncology, Inc.(CGONcusip156944100)	770.0K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$18.9M	0.9% ($18.9M/$2.2B)	QoQ -14.60% (-$3.2M) YoY -44.21% (-$14.9M)
Mereo BioPharma Group plc(MREOcusip589492107)	7.8M	QoQ +53.39% (-2.7M) YoY NEW(+7.8M)	All Managers (Combined)	$17.6M	0.8% ($17.6M/$2.2B)	QoQ -1.38% (-$247.5K) YoY NEW(+$17.6M)
Merus N.V.(MRUScusipN5749R100)	373.1K	QoQ 0.00% (+0) YoY -50.01% (-373.4K)	All Managers (Combined)	$15.7M	0.7% ($15.7M/$2.2B)	QoQ +0.09% (+$14.9K) YoY -53.28% (-$17.9M)
Avidity Biosciences, Inc.(RNAcusip05370A108)	525.0K	QoQ NEW(+525.0K) YoY NEW(+525.0K)	All Managers (Combined)	$15.5M	0.7% ($15.5M/$2.2B)	QoQ NEW(+$15.5M) YoY NEW(+$15.5M)
HilleVax, Inc.(HLVXcusip43157M102)	10.6M	QoQ 0.00% (-0) YoY +8.54% (-835.6K)	All Managers (Combined)	$15.4M	0.7% ($15.4M/$2.2B)	QoQ -29.95% (-$6.6M) YoY -90.53% (-$147.3M)
Dyne Therapeutics, Inc.(DYNcusip26818M108)	1.4M	QoQ NEW(+1.4M) YoY NEW(+1.4M)	All Managers (Combined)	$15.1M	0.7% ($15.1M/$2.2B)	QoQ NEW(+$15.1M) YoY NEW(+$15.1M)
Zai Lab Ltd(ZLABcusip98887Q104)	350.0K	QoQ NEW(+350.0K) YoY NEW(+350.0K)	All Managers (Combined)	$12.6M	0.6% ($12.6M/$2.2B)	QoQ NEW(+$12.6M) YoY NEW(+$12.6M)
Immunocore Holdings plc(IMCRcusip45258D105)	301.2K	QoQ +176.90% (+192.4K) YoY NEW(+301.2K)	All Managers (Combined)	$8.9M	0.4% ($8.9M/$2.2B)	QoQ +178.50% (+$5.7M) YoY NEW(+$8.9M)
Oric Pharmaceuticals, Inc.(ORICcusip68622P109)	1.4M	QoQ -63.73% (-2.5M) YoY -65.96% (-2.7M)	All Managers (Combined)	$7.9M	0.4% ($7.9M/$2.2B)	QoQ -74.92% (-$23.5M) YoY -86.18% (-$49.1M)
ACADIA PHARMACEUTICALS INC(ACADcusip004225108)	470.3K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$7.8M	0.4% ($7.8M/$2.2B)	QoQ -9.48% (-$818.4K) YoY -10.16% (-$884.2K)
Design Therapeutics, Inc.(DSGNcusip25056L103)	2.0M	QoQ 0.00% (-0) YoY NEW(+2.0M)	All Managers (Combined)	$7.5M	0.3% ($7.5M/$2.2B)	QoQ -37.43% (-$4.5M) YoY NEW(+$7.5M)
ROCKET PHARMACEUTICALS, INC.(RCKTcusip77313F106)	1.1M	QoQ -27.04% (-400.0K) YoY -30.88% (-482.2K)	All Managers (Combined)	$7.2M	0.3% ($7.2M/$2.2B)	QoQ -61.28% (-$11.4M) YoY -82.88% (-$34.9M)
Autolus Therapeutics plc(AUTLcusip05280R100)	4.6M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$7.2M	0.3% ($7.2M/$2.2B)	QoQ -34.04% (-$3.7M) YoY -75.70% (-$22.3M)
Oruka Therapeutics, Inc.(ORKAcusip687604108)	583.3K	QoQ 0.00% (-0) YoY NEW(+583.3K)	All Managers (Combined)	$6.0M	0.3% ($6.0M/$2.2B)	QoQ -47.08% (-$5.3M) YoY NEW(+$6.0M)
Allogene Therapeutics, Inc.(ALLOcusip019770106)	3.9M	QoQ +34.90% (-1.0M) YoY +34.90% (-1.0M)	All Managers (Combined)	$5.6M	0.3% ($5.6M/$2.2B)	QoQ -7.52% (-$459.9K) YoY -55.93% (-$7.2M)
Immatics N.V.(IMTXcusipN44445109)	1.2M	QoQ -41.90% (-900.0K) YoY NEW(+1.2M)	All Managers (Combined)	$5.6M	0.3% ($5.6M/$2.2B)	QoQ -63.14% (-$9.6M) YoY NEW(+$5.6M)